In this study, we provided more reliable evidence for the anti-atherosclerotic effects of adropin by using ApoE-/-/Enho-/- mice, and further demonstrated that adropin inhibited the occurrence and development of atherosclerosis in high-fat diet (HFD)-fed ApoE-/- mice by inhibiting the EndMT. Here, APOE is linked to atherosclerosis.